Survival models based on the source tumour genetic data revealed comparatively few significant predictive features: the 95% confidence intervals of histone, ATRX and MGMT methylation HR all crossed 1, EGFR amplification and TERT mutants were significantly associated with poorer prognosis (HR 1.64 and 1.23, respectively). The gene discussed is MGMT; the disease is neoplasm.